文献速递胃肠外科肝胆胰外科疝与腹壁外科

HARM评分作为简易质量指标在普外科多病种患者中的应用

Application of a simple, affordable quality metric tool to colorectal, upper gastrointestinal, hernia, and hepatobiliary surgery patients: the HARM score.
PubMed 文献 · Surg Endosc · 2017-12-27

本研究利用Vizient临床数据库2011–2015年525083例结直肠、肝胆、疝和上消化道手术患者,计算由住院时长、30天再入院和死亡率构成的HARM评分,发现HARM评分与Clavien-Dindo并发症率和严重程度显著相关,且择期与急诊入院趋势一致,提示该低成本工具可用于跨机构外科质量比较。

要点

  • HARM评分由住院时长、30天再入院和死亡率构成,简便且低成本。
  • HARM评分升高与Clavien-Dindo并发症率和严重程度增加相关。
  • 择期与急诊入院中HARM评分与并发症率的趋势一致。

核心结论

  • HARM评分是一种易于使用且低成本的质量指标,在多个外科专业中与并发症率及并发症严重程度相关。

研究设计与样本

  • 回顾性数据库研究,利用Vizient临床数据库纳入2011–2015年结直肠、肝胆、上消化道和疝手术患者共525083例。

主要发现

  • 总体53.8%为择期入院,平均HARM评分为2.24;46.2%为急诊入院,平均HARM评分为1.45(p < 0.0001)。
  • 所有HARM组成部分在logistic回归中均与患者并发症相关(p < 0.0001)。
  • 平均住院时长从HARM评分< 2的3.2 ± 1.8天增加至HARM评分> 4的15.1 ± 12.2天(p < 0.001)。
  • 择期入院中,HARM评分< 2、2-< 3、3-4和> 4的并发症率分别为9.3%、23.2%、38.8%和71.6%。
  • 所有手术类别中,无论是否风险调整,HARM评分升高均与Clavien-Dindo并发症严重程度增加相关。

临床怎么用

  • 该工具可跨机构采用以比较外科护理质量,且成本低廉。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Quality is the major driver for both clinical and financial assessment. There remains a need for simple, affordable, quality metric tools to evaluate patient outcomes, which led us to develop the HospitAl length of stay, Readmission and Mortality (HARM) score. We hypothesized that the HARM score would be a reliable tool to assess patient outcomes across various surgical specialties. METHODS: From 2011 to 2015, we identified colorectal, hepatobiliary, upper gastrointestinal, and hernia surgery admissions using the Vizient Clinical Database. Individual and hospital HARM scores were calculated from length of stay, 30-day readmission, and mortality rates. We evaluated the correlation of HARM scores with complication rates using the Clavien-Dindo classification. RESULTS: We identified 525,083 surgical patients: 206,981 colorectal, 164,691 hepatobiliary, 97,157 hernia, and 56,254 upper gastrointestinal. Overall, 53.8% of patients were admitted electively with a mean HARM score of 2.24; 46.2% were admitted emergently with a mean HARM score of 1.45 (p < 0.0001). All HARM components correlated with patient complications on logistic regression (p < 0.0001). The mean length of stay increased from 3.2 ± 1.8 days for a HARM score < 2 to 15.1 ± 12.2 days for a HARM score > 4 (p < 0.001). In elective admissions, for HARM categories of < 2, 2-< 3, 3-4, and > 4, complication rates were 9.3, 23.2, 38.8, and 71.6%, respectively. There was a similar trend for increasing HARM score in emergent admissions as well. For all surgical procedure categories, increasing HARM score, with and without risk adjustment, correlated with increasing severity of complications by Clavien-Dindo classification. CONCLUSIONS: The HARM score is an easy-to-use quality metric that correlates with increasing complication rates and complication severity across multiple surgical disciplines when evaluated on a large administrative database. This inexpensive tool could be adopted across multiple institutions to compare the quality of surgical care.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Brady JT, Ko B, Hohmann SF, et al. Application of a simple, affordable quality metric tool to colorectal, upper gastrointestinal, hernia, and hepatobiliary surgery patients: the HARM score. Surg Endosc. 2017. PMID: 29282576. doi:10.1007/s00464-017-5998-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。